Amalgamated Financial Corp.
NASDAQ:AMALBanks - Regional
+$0.30 today
- Market cap
- $1.46B
- Beta
- 0.81
- P/E (TTM)
- 12.4
- EPS (TTM)
- $3.51
- Dividend yield
- 1.43%
Volume 0.18M
Average 0.14M
AMAL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Amalgamated Financial Corp.NASDAQ: AMAL
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AMAL compares with its peers on the latest reported figures
- AMAL's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for AMAL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
UCBUnited Community Banks, Inc. | LTM Jun 2026 | $0 | — | — | 0.0% |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AMAL) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for AMAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 208.77M | 285.16M | 382.48M | 435.34M | 455.03M |
| Cost of Revenue | 5.94M | 33.65M | 111.44M | 129.15M | 135.23M |
| Gross Profit | 202.83M | 251.51M | 271.05M | 306.19M | 319.8M |
| Gross Margin | 97.2% | 88.2% | 70.9% | 70.3% | 70.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 75.61M | 81.68M | 93.97M | 101.21M | 122.17M |
| Operating Expenses | 132.11M | 143.34M | 146.32M | 160.6M | 179.64M |
| Depreciation & Amortization | 4.85M | 10.35M | 6.4M | 5.43M | 4.82M |
| EBITDA | 75.57M | 118.51M | 131.13M | 151.02M | 144.97M |
| EBITDA Margin | 36.2% | 41.6% | 34.3% | 34.7% | 31.9% |
| Operating Income | 70.73M | 108.16M | 124.73M | 145.32M | 140.1M |
| Operating Margin | 33.9% | 37.9% | 32.6% | 33.4% | 30.8% |
| Interest Income | 180.53M | 258.49M | 358.08M | 401.3M | 422.23M |
| Interest Expense | 6.22M | 18.65M | 96.77M | 118.87M | 124.45M |
| Other Income / Expenses | 0 | 0 | 0 | 269K | 51K |
| Income Before Tax | 70.73M | 108.16M | 124.73M | 145.59M | 140.15M |
| Pre-Tax Margin | 33.9% | 37.9% | 32.6% | 33.4% | 30.8% |
| Income Tax Expense | 17.79M | 26.69M | 36.75M | 39.16M | 35.71M |
| Net Income | 52.94M | 81.48M | 87.98M | 106.43M | 104.45M |
| Net Margin | 25.4% | 28.6% | 23.0% | 24.4% | 23.0% |
| EPS (Basic) | 1.70 | 2.64 | 2.88 | 3.48 | 3.45 |
| EPS (Diluted) | 1.68 | 2.61 | 2.86 | 3.44 | 3.41 |
| Weighted Avg Shares | 31.1M | 30.82M | 30.56M | 30.59M | 29.93M |
| Weighted Avg Shares (Diluted) | 31.51M | 31.19M | 30.79M | 30.94M | 30.27M |
Amalgamated Financial Corp.
NASDAQ:AMAL
Intrinsic Alpha fair value
Locked
Current Price
$49.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.